Protara Therapeutics Statistics
NASDAQ: TARAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.65+0.06 (+2.32%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 2.74 +3.40%
Protara Therapeutics by the numbers
Protara Therapeutics has a market capitalization of $156.6 million based on 59.10M shares outstanding. With trailing EPS of $-1.36, Protara Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.2% below its 50-day average and 44.9% below its 200-day average.
Average daily trading volume is 804.10K shares, or about $2.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TARA valuation vs. peer median
| Metric | TARA | Peer median | Difference |
|---|---|---|---|
| Market cap | $156.60M | $148.95M | +5% |
| Avg. volume | 804.10K | 500.95K | +61% |
Peer median across 8 companies: CRDL, ABOS, CHRS, IPHA, VYGR, MOLN, ARMP, AVXL.
Valuation
- Market cap
- $156.60M
- EPS (TTM)
- $-1.36
- Shares outstanding
- 59.10M
Price and trading
- Previous close
- 2.59
- Open
- 2.59
- Day range
- 2.52 – 2.69
- 52-week range
- 2.51 – 7.82
- 52-week change
- -46.27%
- Beta
- —
- Volume
- 1.22M
- Average volume
- 804.10K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 156.60M
- Forward Pe
- -1.57
- Eps
- -1.36
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.82
- Week52 Low
- 2.51
- Avg Volume
- 804.10K
- Shares Outstanding
- 59.10M
- Ma50
- 3.69
- Ma200
- 4.81
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -66.11%
- Pct From52w Low
- 5.58%